Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03239717 · ClinicalTrials.gov registry record · NA
The Metabolic Response to Reduced Branched-chain Amino Acids in Humans
A NA study, sponsored by University of Wisconsin, Madison.
- Completed
- Registry status
- NA
- Development phase
- 16
- Enrollment target
NCT03239717 is a NA study that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 16 participants.
The verdict
NCT03239717, a NA study, has completed, sponsored by University of Wisconsin, Madison.
- COMPLETED
- Registry status
- NA
- Development phase
- 16 participants
- Enrollment target
Study Summary
Branched-chain amino acids (BCAAs) are essential nutrients that the body obtains from proteins found in food, especially meat, diary products, and legumes. Data from rodent studies suggest that reduction of dietary BCAAs will promote fat mass loss and improved control of blood glucose. The purpose of this study is to test if reduction of dietary BCAAs without reducing calorie intake will lead to similar metabolic benefits in humans. Here the investigators test the feasibility of reducing dietary BCAAs using BCAA-free meal replacement beverages for two months.
Interventions
- OTHER Whey protein powder
- OTHER BCAD2
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2017-11-28 |
| Est. Completion | 2021-07-16 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03239717
The ClinicalTrials.gov registry entry for NCT03239717 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Wisconsin, Madison, which has 1,039 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Whey protein powder is the first listed.
NCT03239717 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03239717 about?
NCT03239717 is a clinical study titled "The Metabolic Response to Reduced Branched-chain Amino Acids in Humans". Branched-chain amino acids (BCAAs) are essential nutrients that the body obtains from proteins found in food, especially meat, diary products, and legumes. Data from rodent studies suggest that reduction of dietary BCAAs will promote fat mass loss and improved control of blood glucose. The purpose o...
What is the current status of trial NCT03239717?
This trial is currently completed. It is a NA study. The enrollment target is 16 participants. The study started on 2017-11-28. Estimated completion is 2021-07-16.
What interventions are being tested in trial NCT03239717?
The interventions under investigation include: Whey protein powder (OTHER), BCAD2 (OTHER).
Who is sponsoring clinical trial NCT03239717?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.